REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,305,236 | +17.2% | 155,536 | +13.3% | 0.00% | +50.0% |
| Q2 2023 | $3,673,631 | +25.3% | 137,332 | +1.4% | 0.00% | 0.0% |
| Q1 2023 | $2,932,201 | +31.1% | 135,374 | +44.9% | 0.00% | +100.0% |
| Q4 2022 | $2,236,015 | +28.8% | 93,394 | +5.4% | 0.00% | 0.0% |
| Q3 2022 | $1,736,415 | +7.8% | 88,598 | +5.6% | 0.00% | 0.0% |
| Q2 2022 | $1,610,787 | -24.3% | 83,869 | +0.7% | 0.00% | 0.0% |
| Q1 2022 | $2,128,917 | +171.5% | 83,272 | +170.0% | 0.00% | – |
| Q4 2021 | $784,000 | -6.3% | 30,844 | +1.3% | 0.00% | -100.0% |
| Q3 2021 | $837,000 | -19.9% | 30,440 | -7.6% | 0.00% | 0.0% |
| Q2 2021 | $1,045,000 | -2.8% | 32,928 | +40.5% | 0.00% | 0.0% |
| Q1 2021 | $1,075,000 | +20.9% | 23,432 | +4.3% | 0.00% | 0.0% |
| Q4 2020 | $889,000 | +23.1% | 22,458 | +8.2% | 0.00% | 0.0% |
| Q3 2020 | $722,000 | +177.7% | 20,748 | +144.0% | 0.00% | – |
| Q2 2020 | $260,000 | – | 8,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |